Leukemias, Lymphomas, and Misc. Flashcards
Leukocytosis
increases leukocyte count
often a normal protective response
Leukopenia
Decrease in leukocyte count
Below ____ = risk of infection
1000/mm 3
Below ____ = life threatening
500/mm 3
Hematologic Neoplasias
Cancer which originates in hematologic tissues of the body - specifically from changes in the stem cells
Metastasis to bone marrow
Ex of hematologic neoplasia
Multiple myeloma
Leukemia
Polycythemia vera
How common is leukemia
9th most common cancer in US
Avg age of diagnosis for leukemia
66
Leukemias (Weissus Blut) is what
primary neoplasm is within the bone marrow
Lympho =
involving lymphoid tissue
Myelo =
involving hematopoietic stem cells
-blastic =
acute
immature cells
-cytic =
chronic
mature cells
Acute leukemias
accumulation of immature (blast) cells
Overcrowding of bone marrow
Anemia might be first s/s
Onset is abrupt
Common clinical findings with acute leukemia
Anemia Coagulopathy DIC Infection Weight loss Bone pain Inc uric acid excretion Liver, spleen, lymph node enlargement
Acute lymphoblastic leukemia (ALL) defined as
more than 30% lymphoblasts
Acute lymphoblastic leukemia (ALL) epidemiology
Accounts for 20% of all leukemias
Most common (57%) in those under 20 yrs
Median age diagnosis is 15
Acute lymphoblastic leukemia (ALL) 5 yr survival
68%
Children 95% attain remission, 80% long term survivial
Adults 40% long term
Acute Myelogenous Leukemia (AML)
Most common (35%)
Variety of subtypes
Peak diagnosis btw 60-70 yrs
Rare to occur in less than 40 yrs
Acute Myelogenous Leukemia (AML) - survivial (5 yr)
27%
Acute Myelogenous Leukemia (AML) - s/s
Typical manifestations
About 2% have neuro s/s including disorientation and HA
Might see CN problems
Acute Myelogenous Leukemia (AML) - treatment
Significantly high WBC count which can cause vascular damage secondary to occlusion
Chemotherapy - phased with the goal of achieving remission
Acute Myelogenous Leukemia (AML) - chemotherapy phased treatment
1 = Induction therapy - eradication of neoplastic cells
2 = Post Remission - delivery of additional drugs to inc eradication effects
3 = Consolidation therapy - stem cell or bone marrow replacement
Maintenance and supportive therapy
Chronic leukemias
slow onset with vague s/s
cells are well differentiated
some functional WBCs are being produced at the same time